Skip to main content
. 2020 Sep 9;69(5):847–859. doi: 10.33549/physiolres.934482

Fig. 6.

Fig. 6

Data are presented as average ± SEM for the protein expression of anabolic markers (mTORC1 pathway), i.e. phospho-Akt (p-Akt), p-mammalian target of rapamycin (p-mTOR) and p-ribosomal protein S6 kinase 1 (p-S6K1). PBS: healthy controls (PBS-injected), CTX-PL: CTX-injected and untreated, CTX-IBU: CTX-injected and ibuprofen-treated. * p<0.05; p=0.05–0.1.